Current Protein Identity:A0A7H0DNF0 New Search
Main Difference Dimensions in This Set
Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
8C9K Structure of Mpox virus poxin Deposited 2023-01-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–195(195 aa)
Chain B 1–195(195 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291 K;100 mM HEPES pH 7.5, 10% (w/v) PEG 8000
Resolution 1.72 Å R-free 0.228
8C9K Structure of Mpox virus poxin Deposited 2023-01-23 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–195(195 aa)
Chain D 1–195(195 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291 K;100 mM HEPES pH 7.5, 10% (w/v) PEG 8000
Resolution 1.72 Å R-free 0.228
8ORV Crystal structure of monkeypox virus poxin in complex with the STING agonist MD1203 Deposited 2023-04-17 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–195(195 aa)
Not recorded VZ6 9-[(1~{S},6~{R},8~{R},9~{R},10~{R},15~{R},17~{R},18~{R})-8-(6-aminopurin-9-yl)-9,18-bis(fluoranyl)-3,12-bis(oxidanyl)-3,12-bis(oxidanylidene)-2,4,7,11,13-pentaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.2.1.0^{6,10}]octadecan-17-yl]-1~{H}-purin-6-one × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291 K;40% (v/v) PEG 300; 0.1M phosphate-citrate, pH 4.2
Resolution 1.65 Å R-free 0.224
8P44 Crystal structure of monkeypox virus poxin in complex with the STING agonist MD1202D Deposited 2023-05-19 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–195(195 aa)
Chain B 1–195(195 aa)
Not recorded WY8 9-[(1~{S},3~{R},6~{R},8~{R},9~{R},10~{R},12~{R},15~{R},17~{R},18~{R})-8-(6-aminopurin-9-yl)-9,18-bis(fluoranyl)-3,12-bis(oxidanylidene)-3,12-bis(sulfanyl)-2,4,7,11,13-pentaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.2.1.0^{6,10}]octadecan-17-yl]-1~{H}-purin-6-one × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291 K;200 mM ammonium nitrate, 20% w/v PEG 3.350
Resolution 1.93 Å R-free 0.261
8P44 Crystal structure of monkeypox virus poxin in complex with the STING agonist MD1202D Deposited 2023-05-19 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–195(195 aa)
Chain D 1–195(195 aa)
Not recorded WY8 9-[(1~{S},3~{R},6~{R},8~{R},9~{R},10~{R},12~{R},15~{R},17~{R},18~{R})-8-(6-aminopurin-9-yl)-9,18-bis(fluoranyl)-3,12-bis(oxidanylidene)-3,12-bis(sulfanyl)-2,4,7,11,13-pentaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.2.1.0^{6,10}]octadecan-17-yl]-1~{H}-purin-6-one × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291 K;200 mM ammonium nitrate, 20% w/v PEG 3.350
Resolution 1.93 Å R-free 0.261
9XUJ Crystal structure of MPXV poxin Deposited 2025-11-24 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–195(195 aa)
Chain B 1–195(195 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M Succinic acid pH 7.0, 15% w/v Polyethylene glycol 3,350
Resolution 1.75 Å R-free 0.235
9XUJ Crystal structure of MPXV poxin Deposited 2025-11-24 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–195(195 aa)
Chain D 1–195(195 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M Succinic acid pH 7.0, 15% w/v Polyethylene glycol 3,350
Resolution 1.75 Å R-free 0.235
9XUP Crystal structure of MPXV poxin in complex with Gp[2'-5']Ap[3'] Deposited 2025-11-24 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–195(195 aa)
Chain B 1–195(195 aa)
Not recorded 9BG 2',5'-GpAp × 2 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;25% w/v Polyethylene glycol 1,500
Resolution 2.01 Å R-free 0.227
9XUT Crystal structure of MPXV poxin in complex with 3'3'-cGAMP Deposited 2025-11-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–195(195 aa)
Chain B 1–195(195 aa)
Not recorded 4BW 2-amino-9-[(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecin-2-yl]-1,9-dihydro-6H-purin-6-one × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M HEPES pH 7.5, 12% w/v Polyethylene glycol 3,350
Resolution 1.81 Å R-free 0.216
9XUT Crystal structure of MPXV poxin in complex with 3'3'-cGAMP Deposited 2025-11-25 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–195(195 aa)
Chain D 1–195(195 aa)
Not recorded 4BW 2-amino-9-[(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecin-2-yl]-1,9-dihydro-6H-purin-6-one × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M HEPES pH 7.5, 12% w/v Polyethylene glycol 3,350
Resolution 1.81 Å R-free 0.216
9XUU Crystal structure of MPXV poxin in complex with c-di-GMP Deposited 2025-11-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–195(195 aa)
Chain B 1–195(195 aa)
Not recorded C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M BICINE pH 8.5, 8% w/v Polyethylene glycol monomethyl ether 5,000
Resolution 1.94 Å R-free 0.202
9XUU Crystal structure of MPXV poxin in complex with c-di-GMP Deposited 2025-11-25 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 1–195(195 aa)
Chain D 1–195(195 aa)
Not recorded C2E 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M BICINE pH 8.5, 8% w/v Polyethylene glycol monomethyl ether 5,000
Resolution 1.94 Å R-free 0.202